IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`Application of—: Gerald Juergen ROTH,et al. ) Art Unit: 1624
`
`U.S. AppIn. No.
`: 11/552,836
`) Examiner:
`JAISLE, Cecilia M.
`Confirmation No.
`: 2766
`US. Filing Date
`: October 25, 2006
`Title of Invention : New (hetero)aryl compounds with MCHantagonistic activity and
`medicaments comprising these compounds
`Attny. Docket No.: 1/1958
`
`Mail Stop Amendment
`ELECTRONICALLY SUBMITTED VIA EFS
`Commissionerfor Patents
`P. O. Box 1450
`Alexandria, VA 22313-1450
`
`CERTIFICATION STATEMENT, FEE AUTHORIZATION & TRANSMITTAL
`LETTER FOR INFORMATIONDISCLOSURE STATEMENT
`
`Sir:
`
`Transmitted herewith concerning the subject application is an Information Disclosure Statement
`(Form 1449A/B) (“Statement”) under 37 C.F.R. §$1.56 and 1.97, as more specifically described
`hereinbelow.
`
`INFORMATION PREVIOUSLY CITED OR SUBMITTED
`CJ
`U.S. Application No.
`(“the parent application’’) is relied on by the above-
`identified applicant for an earlier effective filing date under 35 U.S.C. 120 for the instant
`application. The patents, publications, pending U.S. applications, or other information listed in
`the Statement were previously cited by the Office in the parent application or submitted to the
`Office in the parent application in an information disclosure statement that complied with 37
`CFR 1.98(a)-(c). 37 CFR 1.98(d)
`
`This Statementis being filed: 1) within three (3) monthsofthe filing date
`1.97(b).
`CJ
`of a national application other than a continued prosecution application under 37 C.F.R. §1.53
`(d); ii) within three (3) monthsofthe date of entry of the national stage as set forth in 37 C.F.R.
`§1.491 in an international application; 111) before the mailing ofa first office action on the merits;
`or iv) before the mailing of a first office action after the filing of a request for continued
`examination under 37 C.F.R. §1.114.
`
`This Statementis being filed after the time period specified in 37 C.F.R.
`1.97(c).
`Xx
`$1.97(b), but before the mailing date of: 1) a final action under 37 C.F.R. §1.113, i1) a notice of
`allowance under 37 C.F.R. §1.311, or iii) an action that otherwise closes prosecution in the
`application. This Statement is being accompanied by:
`
`LC]
`
`XX]
`
`A statement as specified in 37 C.F.R. §1.97(e) [see below]; or
`
`Thefee set forth in 37 C.F.R. §1.17(p).
`
`

`

`The Commissioneris hereby authorized to charge paymentof the $180.00
`Xx
`fee set forth in 37 C.F.R. §1.17(p) to Deposit Account No.
`02-2955.
`
`This Statementis being filed after the period specified in 37 C.F.R.
`1.97(d).
`CJ
`§1.97(c) but on or before paymentof the issue fee. This Statement is accompanied by a
`statement as specified in 37 C.F.R. §1.97(e) [see below] and the fee set forth in 37 C.F.R.
`§1.17(p).
`
`[]
`
` 1.97(e).
`CJ
`Each item of information contained in the Statement wasfirst cited in any
`communication from a foreign patent office in a counterpart foreign application not more
`than three (3) monthsprior to the instant filing; or
`[] No item of information contained in the Statement was cited in a communication
`from a foreign patent office in a counterpart foreign application, and, to the knowledge of
`the person signing this certification after making reasonable inquiry, no item of
`information contained in the Statement was knownto any individual designated in 37
`C.F.R. §1.56(c) more than three (3) monthspriorto the instant filing.
`[]
`Thefee set forth in 37 C.F.R. §1.17(p).
`[|
`The Commissioneris hereby authorized to charge paymentof the $180.00
`fee set forth in 37 C.F.R. §1.17(p) to Deposit Account No. 02-2955.
`
`Each item of information contained in the Statement wasfirst cited in any
`1.704(d).
`CJ
`communication from a foreign patent office in a counterpart application, which communication
`wasnot received by any individual designated in section 1.56(c) more than thirty (30) days prior
`to the instantfiling.
`
`The Commissioneris hereby authorized to charge paymentof any additionalfiling fees
`Xx
`required under 37 C.F.R. §1.16 and any patent application processing fees under 37 C.F.R.
`$1.17, or credit any overpayment of same, to Deposit Account No. 02-2955.
`
`International Search Report and Non-English Language References
`CJ
`An English-language search report or equivalent paper from a foreign patentoffice is
`provided.
`CJ
`A foreign-language search report or equivalent paper from a foreign patentoffice is
`provided, and pertinentparts are translated substantively below:
`
`X=
`
`Y=
`
`documentofparticular relevance whenit is taken alone
`
`documentofparticular relevance whenit is combined with another such
`document
`
`A=_document defining the general state of the art
`
`O=_non-written disclosure
`
`

`

`P=
`
`T=
`
`E=
`
`D=
`
`L=
`
`&=
`
`intervening document
`
`document cited to understand the theory or principle underlying the invention
`
`patent document whichhas the benefit of a date earlier than the filing date and
`which was published only onorafterthis filing date
`
`cited in the application
`
`cited for another reason
`
`publication of member of same patent family
`
`[|
`
`Translation of other relevant information on foreign search report:
`
`In the search report, “Seite” means page, “Seiten” means pages, “Verbindungen der
`Formel” means Compoundsof formula, “Beispiele” means examples, and “das ganze
`Dokument” means the entire document, “Spalte” means column, “Zeile” meansline,
`“Abbildungen” meansFigures, “Anspruch” means Claim,“Zusammenfassung” means
`abstract/summary,and “Tabelle” meanstable, and “Tabellen” meanstables “in der
`Anmeldung erwaechnt” meanscited in the application, “Schema” means scheme,“und”
`meansand, “Absatz” means paragraph,“abbildung” meansfigure, “Absendedatum”
`meansdate of dispatch, “Anmeldetag” meansfiling date, “Eintragungstag” means
`registration date, and Bekanntmachungim Patentblatt” means publication date in the
`official journal.
`
`Xx
`
`These references have been provided in the accompanying Statement because they have
`been cited by patent offices outside the United States in the course of prosecution of
`applications which are counterparts to the above identified application or have been cited
`or been presented as arguments in applications pending before the Office that have
`subject matter related to the above-identified application.
`
`Respectfully submitted,
`
`/Mary-Ellen M. Devlin/
`Mary-Ellen M. Devlin, Reg. No. 27,928
`Attorney for Applicant(s)
`
`Patent Department
`Boehringer Ingelheim Corp.
`900 Ridgebury Road, P.O. Box 368
`Ridgefield, CT 06877
`Tel: (203) 798-4866
`
`